Directory

>

Phil Chamberlain

avatar

Phil Chamberlain

Co-Founder, President and CEO | Neomorph, Inc.

San Diego, California, United States

View contact details (it's free)

Phil Chamberlain

Summary

Phil Chamberlain is a distinguished biotechnology leader based in San Diego, California, specializing in innovative drug discovery methods, particularly in targeted protein degradation. His extensive background in structural and chemical biology has facilitated groundbreaking research, including the first structure of thalidomide bound to human cereblon. As the co-founder and CEO of Neomorph, he focuses on developing molecular glue drugs that target previously 'undruggable' proteins. With a Ph.D. from the University of Oxford, Phil has held executive positions at major pharmaceutical companies, including Bristol Myers Squibb and Celgene. His prolific publication record highlights his contributions to the field, particularly in the mechanisms of cereblon modulators. Phil's passion for advancing therapeutic modalities is matched by his commitment to addressing critical health challenges. He is recognized not only for his scientific expertise but also for his leadership in fostering innovation within the biotechnology sector.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Innovation

Organisational experience

Startup Experience

Corporate Experience

Phil Chamberlain

Work Experience

company logo

Co-Founder, President and CEO at

Neomorph, Inc.

February 2020 - Present

company logo

Executive Director, Protein Homeostasis and Structural Biology at

Bristol Myers Squibb

November 2019 - February 2020

company logo

Executive Director at

Bristol Myers Squibb

December 2007 - November 2019

company logo

Postdoctoral Associate / Institute Fellow at

GNF

January 2004 - January 2007

company logo

Doctoral Student at

University Of Oxford

January 2000 - January 2004

💼

Howard Hughes Undergraduate Fellow at

Mount Sinai School Of Medicine

January 1998 - January 1998

Logos provided by Logo.dev

Phil Chamberlain

Education

University of Oxford, D.Phil.

January 1999 - January 2003

University of Oxford, Ba

January 1996 - January 1999

Frequently Asked Questions about Phil Chamberlain

What is Phil Chamberlain email address?

Phil Chamberlain's primary email address is ****@neomorph.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Phil Chamberlain work for?

Phil Chamberlain is a Co-Founder, President and CEO at Neomorph, Inc., a company specializing in Drugs, proprietaries, & sundries.

Where Phil Chamberlain graduated from?

Phil Chamberlain holds a degree in Structural Biology from University of Oxford.

How can I directly contact Phil Chamberlain?

To contact Phil Chamberlain directly, you can use the email address ****@neomorph.com. Complete contact information is available upon registration with Muraena.

Who is Phil Chamberlain?

Phil Chamberlain is a distinguished biotechnology leader based in San Diego, California, specializing in innovative drug discovery methods, particularly in targeted protein degradation. His extensive background in structural and chemical biology has facilitated groundbreaking research, including the first structure of thalidomide bound to human cereblon. As the co-founder and CEO of Neomorph, he focuses on developing molecular glue drugs that target previously 'undruggable' proteins. With a Ph.D. from the University of Oxford, Phil has held executive positions at major pharmaceutical companies, including Bristol Myers Squibb and Celgene. His prolific publication record highlights his contributions to the field, particularly in the mechanisms of cereblon modulators. Phil's passion for advancing therapeutic modalities is matched by his commitment to addressing critical health challenges. He is recognized not only for his scientific expertise but also for his leadership in fostering innovation within the biotechnology sector.

Phil`s contact details

mail

****@neomorph.com

Colleagues

avatar
Ana Grant

VP, Data Sciences

avatar
Rohan Beckwith

VP of Chemistry

avatar
Megan Gates

Vice President, Head of Human Resources & Talent Acquisition

avatar
Bell Zhong

Chief Financial Officer

avatar
Marla Bornstein

Vice President, Business Development

avatar
Mary Matyskiela

Vice President, Molecular Sciences

View Contact details (it's free)
Request Profile Removal